Statins in Traumatic Brain Injury

Neurotherapeutics

Volumn 7, Issue 1, 2010, Pages 62-73

  Wible, Elissa F ^a   Laskowitz, Daniel T ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

closed head injury; HMG CoA reductase inhibitor; neuroinflammation; Statin; traumatic brain injury

Indexed keywords

ATORVASTATIN; CASPASE 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NITRIC OXIDE SYNTHASE; PRAVASTATIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; ROSUVASTATIN; SIMVASTATIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; ENCEPHALITIS; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; SYNAPTOGENESIS; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; BRAIN INJURIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 72949116186     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2009.11.003     Document Type: Article

References (95)

1. Rutland-Brown W., Langlois J.A., Thomas K.E., and Xi Y.L. Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil 21 (2006) 544-548
2. Langlois J.A., Rutland-Brown W., and Wald M.M. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 21 (2006) 375-378
3. Bulger E.M., Nathens A.B., Rivara F.P., Moore M., MacKenzie E.J., and Jurkovich G.J. Management of severe head injury: institutional variations in care and effect on outcome. Crit Care Med 30 (2002) 1870-1876
4. Biros M.H., and Heegaard W. Prehospital and resuscitative care of the head-injured patient. Curr Opin Crit Care 7 (2001) 444-449
5. McKenney J.M. Pharmacologic characteristics of statins. Clin Cardiol 26 (2003) III32-III38
6. Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 19 (2005) 117-125
7. Goldstein J.L., and Brown M.S. Regulation of the mevalonate pathway. Nature 343 (1990) 425-430
8. Cucchiara B., and Kasner S.E. Use of statins in CNS disorders. J Neurol Sci 187 (2001) 81-89
9. Chen S.F., Hung T.H., Chen C.C., et al. Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury. Life Sci 81 (2007) 288-298
10. Wang H., Lynch J.R., Song P., et al. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol 206 (2007) 59-69
11. Lu D., Goussev A., Chen J., et al. Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. J Neurotrauma 21 (2004) 21-32
12. Lu D., Mahmood A., Qu C., Goussev A., Lu M., and Chopp M. Atorvastatin reduction of intracranial hematoma volume in rats subjected to controlled cortical impact. J Neurosurg 101 (2004) 822-825
13. Silvestri S., and Aronson S. Severe head injury: prehospital and emergency department management. Mt Sinai J Med 64 (1997) 329-338
14. Alderson P., and Roberts I. Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev (2005) CD000196
15. Ramilo O., Saez-Llorens X., Mertsola J., et al. Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J Exp Med 172 (1990) 497-507
16. Chen G., Zhang S., Shi J., Ai J., Qi M., and Hang C. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp Neurol 216 (2009) 398-406
17. Tsan M.F., and Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 76 (2004) 514-519
18. Turkoglu O.F., Eroglu H., Okutan O., et al. Atorvastatin efficiency after traumatic brain injury in rats. Surg Neurol 72 (2009) 146-152
19. Chen X.R., Besson V.C., Beziaud T., Plotkine M., and Marchand-Leroux C. Combination therapy with fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, and simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on experimental traumatic brain injury. J Pharmacol Exp Ther 326 (2008) 966-974
20. Ifergan I., Wosik K., Cayrol R., et al. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis. Ann Neurol 60 (2006) 45-55
21. Erdos B., Snipes J.A., Tulbert C.D., Katakam P., Miller A.W., and Busija D.W. Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production. Am J Physiol Heart Circ Physiol 290 (2006) H1264-H1270
22. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F., and Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) investigators. Circulation 100 (1999) 230-235
23. Gensini G.F., Gori A.M., Dilaghi B., et al. Effect of atorvastatin on circulating hsCRP concentrations: A sub-study of the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study. Int J Cardiol (2009 Feb 11) [Epub ahead of print]
24. Ridker P.M., Danielson E., Fonseca F.A., et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373 (2009) 1175-1182
25. Tapia-Perez J.H., Sanchez-Aguilar M., Torres-Corzo J.G., et al. Effect of rosuvastatin on amnesia and disorientation after traumatic brain injury. (NCT003229758). J Neurotrauma 25 (2008) 1011-1017
26. Vink R., and Nimmo A.J. Multifunctional drugs for head injury. Neurotherapeutics 6 (2009) 28-42
27. Zacco A., Togo J., Spence K., et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci 23 (2003) 11104-11111
28. Ponce J., de la Ossa N.P., Hurtado O., et al. Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection. Stroke 39 (2008) 1269-1275
29. Dolga A.M., Nijholt I.M., Ostroveanu A., Ten Bosch Q., Luiten P.G., and Eisel U.L. Lovastatin induces neuroprotection through tumor necrosis factor receptor 2 signaling pathways. J Alzheimers Dis 13 (2008) 111-122
30. Lewelt W., Jenkins L.W., and Miller J.D. Autoregulation of cerebral blood flow after experimental fluid percussion injury of the brain. J Neurosurg 53 (1980) 500-511
31. Wei E.P., Dietrich W.D., Povlishock J.T., Navari R.M., and Kontos H.A. Functional, morphological, and metabolic abnormalities of the cerebral microcirculation after concussive brain injury in cats. Circ Res 46 (1980) 37-47
32. Klauber M.R., Marshall L.F., Luerssen T.G., Frankowski R., Tabaddor K., and Eisenberg H.M. Determinants of head injury mortality: importance of the low risk patient. Neurosurgery 24 (1989) 31-36
33. Murray G.D., Butcher I., McHugh G.S., et al. Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study. J Neurotrauma 24 (2007) 329-337
34. Williams J.K., Sukhova G.K., Herrington D.M., and Libby P. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. J Am Coll Cardiol 31 (1998) 684-691
35. O'Driscoll G., Green D., and Taylor R.R. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95 (1997) 1126-1131
36. Amin-Hanjani S., Stagliano N.E., Yamada M., Huang P.L., Liao J.K., and Moskowitz M.A. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 32 (2001) 980-986
37. Laufs U., La Fata V., Plutzky J., and Liao J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97 (1998) 1129-1135
38. Wang H., Durham L., Dawson H., et al. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction. Neuroscience 144 (2007) 1324-1333
39. McGirt M.J., Woodworth G.F., Pradilla G., et al. Galbraith Award: simvastatin attenuates experimental cerebral vasospasm and ameliorates serum markers of neuronal and endothelial injury in patients after subarachnoid hemorrhage: a dose-response effect dependent on endothelial nitric oxide synthase. Clin Neurosurg 52 (2005) 371-378
40. Lu D., Mahmood A., Goussev A., Qu C., Zhang Z.G., and Chopp M. Delayed thrombosis after traumatic brain injury in rats. J Neurotrauma 21 (2004) 1756-1766
41. Lu D., Mahmood A., Goussev A., et al. Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J Neurosurg 101 (2004) 813-821
42. Lynch J.R., Wang H., McGirt M.J., et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 36 (2005) 2024-2026
43. Qu C., Lu D., Goussev A., Schallert T., Mahmood A., and Chopp M. Effect of atorvastatin on spatial memory, neuronal survival, and vascular density in female rats after traumatic brain injury. J Neurosurg 103 (2005) 695-701
44. Lu D., Qu C., Goussev A., et al. Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury. J Neurotrauma 24 (2007) 1132-1146
45. Wu H., Lu D., Jiang H., et al. Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury. J Neurosurg 109 (2008) 691-698
46. Wu H., Lu D., Jiang H., et al. Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma 25 (2008) 130-139
47. Chen J., Zhang C., Jiang H., et al. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab 25 (2005) 281-290
48. Wang L., Gang Zhang Z., Lan Zhang R., and Chopp M. Activation of the PI3-K/Akt pathway mediates cGMP enhanced-neurogenesis in the adult progenitor cells derived from the subventricular zone. J Cereb Blood Flow Metab 25 (2005) 1150-1158
49. Horwood J.M., Dufour F., Laroche S., and Davis S. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci 23 (2006) 3375-3384
50. Chen J., Zhang Z.G., Li Y., et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53 (2003) 743-751
51. Weis M., Heeschen C., Glassford A.J., and Cooke J.P. Statins have biphasic effects on angiogenesis. Circulation 105 (2002) 739-745
52. Hixon M.L., Muro-Cacho C., Wagner M.W., et al. Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization. J Clin Invest 106 (2000) 1011-1020
53. Narayan R.K., Michel M.E., Ansell B., et al. Clinical trials in head injury. J Neurotrauma 19 (2002) 503-557
54. Rinder L. "Concussive response" and intracranial pressure changes at sudden extradural fluid volume input in rabbits. Acta Physiol Scand 76 (1969) 352-360
55. Wang H., Gao J., Lassiter T.F., et al. Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocrit Care 5 (2006) 71-78
56. Lynch J.R., Pineda J.A., Morgan D., et al. Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema. Ann Neurol 51 (2002) 113-117
57. Lynch J.R., Wang H., Mace B., et al. A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp Neurol 192 (2005) 109-116
58. Zohar O., Schreiber S., Getslev V., Schwartz J.P., Mullins P.G., and Pick C.G. Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice. Neuroscience 118 (2003) 949-955
59. Mahmood A., Goussev A., Lu D., et al. Long-lasting benefits after treatment of traumatic brain injury (TBI) in rats with combination therapy of marrow stromal cells (MSCs) and simvastatin. J Neurotrauma 25 (2008) 1441-1447
60. McGirt M.J., Lynch J.R., Parra A., et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33 (2002) 2950-2956
61. Cheng G., Wei L., Zhi-Dan S., Shi-Guang Z., and Xiang-Zhen L. Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway. BMC Neurosci 10 (2009) 7
62. Sugawara T., Ayer R., Jadhav V., Chen W., Tsubokawa T., and Zhang J.H. Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase. J Neurosci Res 86 (2008) 3635-3643
63. McGirt M.J., Pradilla G., Legnani F.G., et al. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 58 (2006) 945-951
64. Bulsara K.R., Coates J.R., Agrawal V.K., et al. Effect of combined simvastatin and cyclosporine compared with simvastatin alone on cerebral vasospasm after subarachnoid hemorrhage in a canine model. Neurosurg Focus 21 (2006) E11
65. Seyfried D., Han Y., Lu D., Chen J., Bydon A., and Chopp M. Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J Neurosurg 101 (2004) 104-107
66. Jung K.H., Chu K., Jeong S.W., et al. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 35 (2004) 1744-1749
67. Prinz V., Laufs U., Gertz K., et al. Intravenous rosuvastatin for acute stroke treatment: an animal study. Stroke 39 (2008) 433-438
68. Mayanagi K., Katakam P.V., Gaspar T., Domoki F., and Busija D.W. Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia. J Cereb Blood Flow Metab 28 (2008) 1927-1935
69. Sironi L., Cimino M., Guerrini U., et al. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol 23 (2003) 322-327
70. Naval N.S., Abdelhak T.A., Zeballos P., Urrunaga N., Mirski M.A., and Carhuapoma J.R. Prior statin use reduces mortality in intracerebral hemorrhage. Neurocrit Care 8 (2008) 6-12
71. Naval N.S., Abdelhak T.A., Urrunaga N., Zeballos P., Mirski M.A., and Carhuapoma J.R. An association of prior statin use with decreased perihematomal edema. Neurocrit Care 8 (2008) 13-18
72. Leker R.R., Khoury S.T., Rafaeli G., Shwartz R., Eichel R., and Tanne D. Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke 40 (2009) 2581-2584
73. FitzMaurice E., Wendell L., Snider R., et al. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke 39 (2008) 2151-2154
74. Elkind M.S., Sacco R.L., MacArthur R.B., et al. The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke. Int J Stroke 3 (2008) 210-218
75. Tseng M.Y., Czosnyka M., Richards H., Pickard J.D., and Kirkpatrick P.J. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 36 (2005) 1627-1632
76. Chou S.H., Smith E.E., Badjatia N., et al. A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke 39 (2008) 2891-2893
77. Vergouwen M.D., Meijers J.C., Geskus R.B., et al. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab 29 (2009) 1444-1453
78. Kerz T., Victor A., Beyer C., Trapp I., Heid F., and Reisch R. A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: incidence of delayed cerebral ischemia and mortality. Neurol Res 30 (2008) 893-897
79. Kramer A.H., Gurka M.J., Nathan B., Dumont A.S., Kassell N.F., and Bleck T.P. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery 62 (2008) 422-430
80. McGirt M.J., Garces Ambrossi G.L., Huang J., and Tamargo R.J. Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study. J Neurosurg 110 (2009) 968-974
81. Kern M., Lam M.M., Knuckey N.W., and Lind C.R. Statins may not protect against vasospasm in subarachnoid haemorrhage. J Clin Neurosci 16 (2009) 527-530
82. Tseng M.Y., Hutchinson P.J., Turner C.L., et al. Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial. J Neurosurg 107 (2007) 1092-1100
83. STASH Trial: SimvaSTatin in Aneurysmal Subarachnoid Hemorrhage. www.stashtrial.com Accessed August 18, 2009
84. Margulies S., and Hicks R. Combination therapies for traumatic brain injury: prospective considerations. J Neurotrauma 26 (2009) 925-939
85. Besson V.C., Chen X.R., Plotkine M., and Marchand-Verrecchia C. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury. Neurosci Lett 388 (2005) 7-12
86. Balduini W., Mazzoni E., Carloni S., et al. Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1beta and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression. Stroke 34 (2003) 2007-2012
87. Saheki A., Terasaki T., Tamai I., and Tsuji A. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm Res 11 (1994) 305-311
88. Miron V.E., Zehntner S.P., Kuhlmann T., et al. Statin therapy inhibits remyelination in the central nervous system. Am J Pathol 174 (2009) 1880-1890
89. Amarenco P., Bogousslavsky J., Callahan III A., et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
90. Bang O.Y., Saver J.L., Liebeskind D.S., et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 68 (2007) 737-742
91. Blanco M., Nombela F., Castellanos M., et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 69 (2007) 904-910
92. Singhal A.B., Topcuoglu M.A., Dorer D.J., Ogilvy C.S., Carter B.S., and Koroshetz W.J. SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 64 (2005) 1008-1013
93. Menon D.K. Unique challenges in clinical trials in traumatic brain injury. Crit Care Med 37 (2009) S129-S135
94. Tseng M.Y., Hutchinson P.J., Czosnyka M., Richards H., Pickard J.D., and Kirkpatrick P.J. Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 38 (2007) 1545-1550
95. Montaner J., Chacon P., Krupinski J., et al. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol 15 (2008) 82-90